Historical record - last NADAC effective date: 9/23/2020
Product Information
HYDROCODONE ER 50 MG CAPSULE is a generic product labeled by Alvogen Inc., priced at $8.7548 per EA under NDC 47781041460. Its NADAC has been published 52 times since Sep 23, 2020.
FDA first approved this application on Jan 21, 2020.
Strength
50 mg/1
Manufacturer
Alvogen Inc.NDC
47781041460
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2020
Active Ingredients
HYDROCODONE BITARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA206986FDA Approved
1/21/2020
On Market Since
1/21/2020
Pharmacological Classes
Price Statistics
The NADAC for HYDROCODONE ER 50 MG CAPSULE has been published 52 times since Sep 23, 2020, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.7548 per EA |
|---|---|
| All-time high | $8.7548 (Sep 15, 2021) |
| All-time low | $8.7548 (Sep 23, 2020) |
| Median price | $8.7548 |
| Average price | $8.7548 |
| Largest weekly change | 0.0% (Sep 30, 2020) |
| Weeks tracked | 52 |
| Tracking since | Sep 23, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Sep 15, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Hydrocodone Bitartrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alvogen Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydrocodone Bitartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROCODONE ER 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE ER 50 MG CAPSULE, manufactured by Alvogen Inc., is $8.7548 per EA (NDC 47781041460), effective Sep 15, 2021.
How has the price of HYDROCODONE ER 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for HYDROCODONE ER 50 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 52 weekly CMS publications since Sep 23, 2020.
What are the highest and lowest recorded NADAC prices for HYDROCODONE ER 50 MG CAPSULE?
Since Sep 23, 2020, the NADAC for HYDROCODONE ER 50 MG CAPSULE has ranged from a low of $8.7548 (Sep 23, 2020) to a high of $8.7548 (Sep 15, 2021), with a median of $8.7548 per EA.
Are there cheaper alternatives to HYDROCODONE ER 50 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of HYDROCODONE ER 50 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROCODONE ER 50 MG CAPSULE?
HYDROCODONE ER 50 MG CAPSULE (NDC 47781041460) is labeled by Alvogen Inc., and CMS classifies it as a generic product.